BDSX - Biodesix, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 113.07M
Enterprise value 101.83M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.60
Price/book (mrq)5.49
Enterprise value/revenue 2.50
Enterprise value/EBITDA -1.92

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3-6.76%
S&P500 52-week change 31.77%
52-week high 33.0000
52-week low 30.9550
50-day moving average 31.6381
200-day moving average 31.7002

Share statistics

Avg vol (3-month) 385.59k
Avg vol (10-day) 397.31k
Shares outstanding 578.46M
Implied shares outstanding 6N/A
Float 815.72M
% held by insiders 164.39%
% held by institutions 115.00%
Shares short (14 May 2023) 4256.07k
Short ratio (14 May 2023) 45.34
Short % of float (14 May 2023) 40.85%
Short % of shares outstanding (14 May 2023) 40.33%
Shares short (prior month 13 Apr 2023) 4335.26k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -168.38%
Operating margin (ttm)-128.88%

Management effectiveness

Return on assets (ttm)-46.05%
Return on equity (ttm)-1,112.04%

Income statement

Revenue (ttm)40.72M
Revenue per share (ttm)0.76
Quarterly revenue growth (yoy)38.30%
Gross profit (ttm)24.06M
EBITDA -49.01M
Net income avi to common (ttm)-68.56M
Diluted EPS (ttm)-1.3500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.27M
Total cash per share (mrq)0.32
Total debt (mrq)38.94M
Total debt/equity (mrq)855.71
Current ratio (mrq)1.57
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-39.56M
Levered free cash flow (ttm)-43.49M